Bioactive glass is a synthetic material made primarily from silica, calcium, sodium, and phosphorus that can bond directly to living bone and soft tissue. Unlike conventional glass, which is inert, bioactive glass triggers a chemical reaction when it contacts body fluids, prompting the body to grow new bone at the implant site. First discovered in 1969 and in clinical use since 1985, it has become a versatile tool in orthopedic surgery, dentistry, and wound care.
What Bioactive Glass Is Made Of
The original and most widely studied formulation, known as 45S5, contains 45% silicon dioxide, 24.5% sodium oxide, 24.5% calcium oxide, and 6% phosphorus pentoxide by weight. What makes this recipe special is the unusually high proportion of sodium and calcium relative to phosphorus. That ratio makes the glass surface extremely reactive when it meets the wet, salty environment inside your body. Other formulations have been developed since, tweaking these proportions or adding elements like boron or strontium, but the 45S5 composition remains the benchmark.
How It Bonds to Bone
When bioactive glass is placed in the body, it doesn’t just sit there like a metal screw or plastic implant. It kicks off a multi-step chemical reaction with surrounding fluids. First, ions from the glass surface (mainly sodium and calcium) exchange with hydrogen ions in body fluid, creating a silica-rich layer on the surface. Phosphate and calcium ions from both the glass and the surrounding fluid then deposit on top of that layer in an amorphous, water-rich form.
Over time, water molecules gradually diffuse out of this deposit, and it crystallizes into hydroxycarbonate apatite, a mineral that is chemically and structurally identical to the mineral component of natural bone. This is the key step. Because the surface now looks like real bone mineral to your body, bone-forming cells attach to it and begin laying down new tissue. The glass essentially tricks the body into treating it as part of the skeleton.
Uses in Orthopedic and Facial Surgery
Bioactive glass serves as a bone graft substitute in situations where a patient’s own bone isn’t available or harvesting it would cause additional pain. In craniofacial surgery, granules and plates have been used to reconstruct orbital floors after blowout fractures, obliterate frontal sinuses, repair nasal septal perforations, and augment the maxillary sinus floor before dental implants. Surgeons have also used it to fill defects left after benign bone tumor removal, where autologous bone grafts have traditionally been the standard.
In spinal surgery, bioactive glass granules have been tested alongside metal screws for stabilizing lumbar burst fractures. For tibial plateau fractures, randomized studies have compared bioactive glass directly against the patient’s own bone graft. Results across these applications have been promising, though the strongest track record so far is in craniofacial reconstruction and infection treatment.
Built-In Infection Fighting
One of the more useful properties of bioactive glass is that it naturally discourages bacterial growth. As ions leach from the glass surface, the local pH rises into an alkaline range that bacteria struggle to tolerate. At the same time, osmotic pressure around the granules increases. Together, these changes create an environment that is hostile to microbes without damaging the patient’s own tissue.
There’s also a mechanical component. Tiny, needle-like fragments of glass can physically damage bacterial cell walls, creating holes that make bacteria more vulnerable to the body’s immune defenses. This combination of chemical and physical antibacterial action has made bioactive glass particularly valuable for treating chronic bone infections (osteomyelitis), where bacteria are deeply entrenched and notoriously difficult to clear. In chronic ear infections requiring mastoid obliteration, bioactive glass granules have been used successfully in multiple clinical studies.
Bioactive Glass in Dentistry
A fine-particle version of bioactive glass, sold under the name NovaMin, is used in toothpastes and professional dental products to treat tooth sensitivity and promote remineralization. When these particles contact saliva, they release calcium and phosphorus ions that form a layer of hydroxycarbonate apatite over exposed dentin tubules, the microscopic channels in tooth structure that transmit pain signals to the nerve.
In clinical testing, a single professional application of NovaMin powder reduced dentin hypersensitivity by roughly 76 to 81% immediately after treatment. The effect does fade over weeks, with reduction dropping to about 61% at the four-week mark in one trial, suggesting that repeated application or use in a daily toothpaste provides the most consistent relief. The mineral layer it deposits is chemically identical to natural tooth mineral, so it integrates with existing enamel and dentin rather than simply coating over them.
Wound Healing Beyond Bone
Bioactive glass isn’t limited to hard tissue. Borate-based formulations have been developed specifically for soft tissue wounds. One FDA-cleared product, the Mirragen Advanced Wound Matrix, is made entirely of resorbable borate glass fibers. These fibers dissolve gradually in the wound bed, releasing ions that promote blood vessel formation and tissue repair while the matrix itself provides a scaffold for new tissue to grow into. This extends the reach of bioactive glass technology into chronic wound management, a very different clinical setting from the orthopedic applications where it started.
How It Compares to Hydroxyapatite
Hydroxyapatite, the other widely used bone-repair ceramic, is chemically similar to the mineral that bioactive glass eventually converts into. But the two materials behave differently once implanted. In rat studies comparing the two in critical-size skull defects, hydroxyapatite was resorbed faster and stimulated more new bone formation at 30 and 60 days. Bioactive glass, by contrast, maintained a greater volume in the defect over the same period because it dissolves more slowly.
The faster resorption of hydroxyapatite appears to be driven by a stronger cellular cleanup response: more bone-resorbing cells were found around hydroxyapatite particles. This means hydroxyapatite may be preferable when rapid bone turnover is the goal, while bioactive glass may suit situations where longer-term structural support or antimicrobial protection matters more. The choice between them depends on the clinical scenario rather than one being universally superior.
Newer Designs for Drug Delivery
A newer class called mesoporous bioactive glass takes the basic chemistry and adds an internal network of tiny, ordered channels. These channels give the material a dramatically larger surface area and pore volume compared to conventional bioactive glass. That extra internal space can be loaded with medications or growth factors at efficiencies well above the roughly 15% ceiling typical of standard bioceramics.
Once implanted, the drug releases slowly as the glass dissolves, delivering medication directly to the site that needs it. The pore size can be tuned during manufacturing, which gives researchers control over how quickly the drug escapes. This makes mesoporous bioactive glass a potential platform for localized antibiotic delivery in infected bone, or for releasing growth factors that accelerate healing in large defects.
Safety Considerations
Bioactive glass is generally well tolerated, which is why it has remained in clinical use for nearly four decades. However, the same ion release that makes it effective can occasionally cause problems. The original 45S5 formulation can produce a sharp local pH spike from rapid sodium and calcium leaching, which in some laboratory settings has shown cytotoxic effects on cells. This is more of a concern with large quantities of fine particles in enclosed spaces than with typical clinical use.
Some formulations incorporate silver ions to boost antimicrobial performance, but high silver concentrations have been reported to be toxic to cells. Composite versions that blend bioactive glass into dental resins have also shown cytotoxicity in lab tests, likely from unreacted resin components rather than the glass itself. These issues are material-specific and dose-dependent, not blanket risks of the technology.